AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 176 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $3,074,000 | -91.5% | 227,717 | -84.8% | 3.79% | -75.8% |
| Q4 2019 | $36,289,000 | +17.9% | 1,501,400 | -6.3% | 15.66% | +57.4% |
| Q3 2019 | $30,789,000 | +30.1% | 1,601,900 | +100.0% | 9.95% | +48.7% |
| Q2 2019 | $23,670,000 | +135.2% | 801,000 | +278.1% | 6.69% | +85.0% |
| Q1 2019 | $10,062,000 | +6.5% | 211,823 | -19.1% | 3.62% | -16.6% |
| Q4 2018 | $9,452,000 | – | 261,823 | – | 4.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |